Search for: "Generic Pharmaceutical Services, Inc." Results 61 - 80 of 1,031
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2009, 2:56 pm
The Department of Justice announced last week that it has entered into a multi-million dollar civil settlement agreement with Aventis Pharmaceutical, Inc., a subsidiary of Sanofi Aventis U.S. [read post]
29 Nov 2017, 3:29 am
In re Boehringer Ingelheim Pharmaceuticals, Inc., Serial No. 86852106 (November 27, 2017) [not precedential] (Opinion by Judge Frances Wolfson).The Board ignored applicant's feeble double entendre argument, but it agreed with applicant that the USPTO's evidence failed to show that the term "breathless" merely describes the subject services. [read post]
13 Mar 2019, 9:10 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., et al. v. [read post]
19 Nov 2010, 2:24 pm by The Farber Law Group
Food and Drug Administration report that Xanodyne Pharmaceuticals Inc., manufacturer of Davon and Darvocet, has agreed to pull the two pain medication from the market due to risk of potentially serious or fatal side effects including heart rhythm abnormalities and also because of concerns that too many patients have overdosed on the drug. [read post]
30 Dec 2021, 5:06 am
Sean Kelly, Cancellation No. 92063940 [Petition for cancellation of a registration for the mark VELOCETTE for "Coats; Jackets; Shirts; T-shirts; Tops," on the ground of likelihood of confusion with the identical common law mark used, under license, in connection with various clothing items.]January 12, 2022 - 2 PM: In re Alembic Pharmaceuticals, Inc., Serial No. 88660548 [Section 2(d) refusal of ALEMBIC for "Generic prescription drugs, approved by the U.S. [read post]
4 Jun 2015, 8:00 am by Greene LLP
Whether a use is covered under the programs generally depends on whether medical items or services are reasonable and necessary. [read post]
2 Sep 2014, 4:57 am
September 24, 2014 - 2 PM: In re Ren Acquisition, Inc., Serial Nos. 85787527 and 85787531 [Section 2(e)(1) mere descriptiveness refusal of BLENDS and BLENDS, INC. for "marketing, advertising, and promoting the sale of wine"].Read comments and post your comment here.TTABlog note: Any predictions? [read post]
22 Aug 2017, 5:00 am by Donovan Gibbons
” In response, the Shareholders argued that the sales of tobacco products by pharmaceutical companies constituted an exception to this general rule as implicating a significant policy issues. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
29 Mar 2019, 3:13 am
Millennium Pharmaceuticals LLC, Opposition No. 91228995 [Opposition to registration of the mark 1 POINT for "Business administration of patient reimbursement program; Business administration of medication reimbursement programs; Providing insurance information and insurance reimbursement information; providing financial assistance for prescription cost; Providing medical and scientific research information to patients relating to the management of hematological malignancies, cancer, … [read post]
2 Oct 2012, 5:36 am by Ben Vernia
According to the Department of Justice’s press release: Pharmaceutical manufacturer Abbott Laboratories Inc. was sentenced by U.S. [read post]
10 Dec 2020, 3:50 am
"] In re Globus Medical, Inc., Serial No. 88676830 (December 8, 2020) [not precedential] (Opinion by Judge Christen M. [read post]
27 Sep 2010, 1:09 pm by Rebecca Shafer, J.D.
(WCxKit) Rotor Mechanical Services Ltd. faces a number of charges, including failing, as an employer, to ensure a gas generator was properly installed and operated. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
Attorney’s Office for the District of Delaware, the Health and Human Services Office of the Inspector General, the U.S. [read post]
16 Aug 2021, 6:32 am by Robert Kraft
” In the proposed settlement, US state attorneys general are expected to announce “McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp contributing a combined $21 billion, while Johnson & Johnson would pay $5 billion. [read post]
3 Apr 2009, 5:10 am
Nagler, senior vice president and general counsel at toy maker Hasbro Inc. since 2000, led the legal charge against Scrabulous. [read post]